Team
The people behind Evolvia.
A lean, capital-efficient team combining PHD/EGLN biology, precision-medicine, and industry-grade development experience.
Core team
Md Karim Ullah, PhD
Founder & CEO
University of Chicago
PhD in Biochemistry & Molecular Medicine (Oulu); UChicago postdoc. Leads compound design and validation. Foundational PHD/EGLN biology (2017 Sci. Rep.).
Muhammad Rafiqul Islam, MD
Global Communications
University of Chicago (MS)
Physician (MD); MS in Precision Medicine, University of Chicago. Leads external and scientific communications (remote).
How we work
Lean & capital-efficient
Outsourced synthesis (Enamine) and academic-core validation, with a parallel non-dilutive NIH SBIR track — capital flows into experiments, not fixed infrastructure.
Focused
One program: isoform-selective PHD1 inhibitors for MSS colorectal cancer. Key scientific and operational hires planned as funding advances.